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Biosynthetic pathways can be hijacked to yield novel
compounds by introduction of novel starting mate-
rials. Here we have altered tryptamine, which serves
as the starting substrate for a variety of alkaloid
biosynthetic pathways, by replacing the indole with
one of four aza-indole isomers. We show that two
aza-tryptamine substrates can be successfully incor-
porated into the products of the monoterpene indole
alkaloid pathway in Catharanthus roseus. Use of
unnatural heterocycles in precursor-directed bio-
synthesis, in both microbial and plant natural prod-
uct pathways, has not been widely demonstrated,
and successful incorporation of starting substrate
analogs containing the aza-indole functionality has
not been previously reported. This work serves as
a starting point to explore fermentation of aza-alka-
loids from other tryptophan- and tryptamine-derived
natural product pathways.INTRODUCTION
Aza-indoles are important pharmacophores that mimic the
indole scaffold. These unique heterocycles are isosteric to the
indole moiety, but display improved water solubility and unique
hydrogen bonding properties (Merour and Joseph, 2001).
Several natural products contain aza-indole moieties (Perry
et al., 1994; Schumacher and Davidson, 1995; Trimurtulu et al.,
1994), and the antitumor properties of a synthetic aza analog
of the indole natural product rebeccamycin have also been
examined (Marminon et al., 2003) (Figure 1). Moreover, a number
of synthetic drug candidates contain the aza-indole scaffold
(Leblanc et al., 2009; Tsai et al., 2008; Wang et al., 2003)
(Figure 1). We synthesized aza-tryptamines 1-4 and demon-
strated that two of these compounds, 1 and 4, could serve as
surrogates for tryptamine in the monoterpene indole alkaloid
biosynthetic pathway to generate aza-alkaloids (Figure 2).
Notably, these two deactivated aza-indole substrates were
successfully utilized in an enzymatic Pictet-Spengler reaction,
a key step in this biosynthetic pathway.
A general synthetic procedure for the production of 4-, 5-, 6-,
and 7- aza-tryptamine 1-4 was developed. Ortho-iodoanilines,
which were either commercially available or were prepared by
copper-catalyzed halogen exchange reaction using the diamine
ligand trans-N,N0-dimethylcyclohexane (Klapars and Buchwald,Chemistry & Biology 16, 1225–1222002) (Figure 2), could be subjected to palladium-catalyzed het-
eroannulation with a trimethylsiliated alkyne, followed by the acid
hydrolysis to give all four 3-substituted aza-indole products in
good yields (Pullagurla et al., 2005; Ujjainwalla and Warner,
1998) (Figure 2).
We investigated the use of aza-tryptamines in a Pictet-Spen-
gler reaction, which is widely used in synthetic organic chemistry
(Royer et al., 2004), and also serves as the first committed enzy-
matic step in a number of alkaloid biosynthetic pathways
(O’Connor and Maresh, 2006) (Figure 3). In the Pictet-Spengler
reaction, tryptamine 5 reacts with an aldehyde to form an imi-
nium ion. The nucleophilic indole then attacks the iminium ion,
resulting in the formation of a tetrahydro-b-carboline product
(Figure 3) (Maresh et al., 2008). Because aza-tryptamines are
more electron deficient than tryptamine 5, the efficiency of the
Pictet-Spengler reaction is expected to be greatly decreased
with substrates 1-4. However, when incubated with both the
aldehyde secologanin 6 and the ‘‘Pictet-Spenglerase’’ strictosi-
dine synthase from themonoterpene indole alkaloid biosynthetic
pathway in Catharanthus roseus, 4- and 7-aza-tryptamines 1
and 4 were converted into the corresponding aza-tetrahydro-
b-carboline products 7 and 10. No product formation was
observed with 5- and 6-aza-tryptamines 2 and 3. Overall, the
catalytic efficiency of 7-aza-tryptamine 4 (kcat: 11.8 ± 0.4 min
1
and KM: 65 mM ± 9.1) was approximately 100-fold lower
compared with tryptamine 5 (kcat: 96 ± 4.7 min
1 and KM: 5 mM±
1.4), and 4-aza-tryptamine 1 (kcat: 10.2 ± 0.3 min
1 and a KM:
151 mM ± 9.3) was 280-fold reduced relative to tryptamine 5.
Strictosidine synthase, in general, has been shown to display
a greater tolerance for substituents at the 4 and 7 positions of the
indole ring compared with substituents at the 5 and 6 positions
(Figure 3) (Bernhardt et al., 2007; Loris et al., 2007; McCoy
et al., 2006), a pattern consistent with the reactivity observed
with aza-tryptamines 1-4. Although steric factors did not seem
likely to play a major role in the recognition of the aza-trypt-
amines—the size of nitrogen (van der Waals radius 1.55 A˚) is
similar to carbon (1.70 A˚) —hydrogen bonding properties of the
aza-indoles could affect whether the substrate interacts produc-
tively with the enzyme. Given that 7-aza-tryptamine 4 is the best
substrate of the series, it is notable that the 7-position of the
indole ring is pointed toward the solvent, away from any protein
contact, while 4, 5, and 6 positions are located in the interior of
the protein (Ma et al., 2006).
We asked whether the differing electronic properties of 1-4
also played a role in the relative rates of enzymatic reaction,
since the Pictet-Spengler reaction depends upon the electron
density of the aromatic amine substrate. After formation of the
iminium ion, the Pictet-Spengler reaction can proceed by one9, December 24, 2009 ª2009 Elsevier Ltd All rights reserved 1225
Figure 1. The Aza-indole Moiety (Highlighted in Red) in Natural and
Synthetic Compounds
(A) Aza-indoles in natural products.
(B) Aza-indole moiety in an indole natural product analog.
(C) Synthetic pharmaceutically important compounds containing an aza-
indole group.
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attack the iminium moiety to form the cyclized intermediate
shown in Figure 3. Alternatively, the C3 carbon can attack the
iminium moiety to form a spiro intermediate, which then
undergoes a 1,2 shift to rearrange to the cyclized intermediate
shown in Figure 3. Computational evidence suggests that C2,
rather than C3, specifically acts as the nucleophile that attacks
the iminium moiety, and that the spiro intermediate is not part
of the productive reaction mechanism (Figure 3) (Kowalski
et al., 1995; Maresh et al., 2008). Therefore, it is the electron
density of the C2 position that should have the most impact
upon the relative reactivity of 1-4. Because electron density
can be inferred from 13C chemical shifts (Lauterbur, 1961),
1H-13C-HSQC spectroscopy was used to measure the chemical
shifts of the C2 atom in 1-4. These measurements indicated that
the C2 position of 7-aza-tryptamine 4 (115.9 ppm) is the most
electron rich, followed by 5-aza-tryptamine 2 (131.0 ppm), then
4-aza-tryptamine 1 (135.2 ppm) and lastly 6-aza-tryptamine 3
(137.5 ppm). Although these data are consistent with previous
reports that 4- and 6-aza-indoles are more deactivated than 5-
and 7-aza-indoles (Zhang et al., 2002), the electronic density ofFigure 2. Synthesis of Aza-tryptamine Compounds 1-4
1226 Chemistry & Biology 16, 1225–1229, December 24, 2009 ª2009these aza-indole substrates does not correspond to the order
of enzyme reactivity, where 7-aza-tryptamine 4 > 4-aza-trypt-
amine 1 > > > 5-aza-tryptamine 2 6-aza-tryptamine 3. There-
fore, we conclude that the electron density of the C2 atom of
the aza-tryptamines is not the dominating factor in enzymatic
reactivity.
It is also known that the pyridine moieties of 5- and 6-aza-
indoles are more basic than 4- and 7-aza-indoles (7-aza-indole
pKa: 4.6, 4-aza-indole pKa: 6.9, 6-aza-indole pKa; 7.9, 5-aza-
indole pKa: 8.3 [Adler and Albert, 1963]). Therefore, 5- and
6-aza-tryptamines 2 and 3 are more likely to be protonated at
neutral pH. Protonation of the pyridine would reduce the electron
density of the aza-indole, and the rate of the Pictet-Spengler
reaction would be further diminished. However, although stricto-
sidine synthase is active at pH 8 (Maresh et al., 2008), both 2 and
3 still failed to form product when incubated with strictosidine
synthase and 6 at this more basic pH value. Additionally, the
tryptamine-binding pocket of strictosidine synthase consists
primarily of hydrophobic residues (Ma et al., 2006), suggesting
that an amino acid of the enzyme does not protonate the pyridine
ring of any of the aza-tryptamines. Therefore, we conclude that
neither the higher pKa values of 5- and 6-aza-tryptamines, nor
the corresponding protonation state of the pyridine moiety, are
responsible for the lack of enzymatic reactivity with 2 and 3.
Instead, the reactivity is consistent with the previously reported
substrate specificity of strictosidine synthase, in which trypt-
amine analogs with a variety of substituents at the 4 and 7 posi-
tions are accepted, while most substrates substituted at the
5 and 6 positions are not (Bernhardt et al., 2007; Loris et al.,
2007; McCoy et al., 2006). Importantly, the aza group has
different hydrogen bonding properties and is much more hydro-
philic than the corresponding carbocycle. In addition to discrim-
inating against 5- and 6 substituted tryptamines for steric
reasons, strictosidine synthase also discriminates against these
isosteric changes.
It is notable that strictosidine synthase allows turnover of
chemically deactivated substrates. We speculate that for
successful turnover of 1 and 4, the enzyme uses the active site
glutamic acid residue to keep the iminium ion nitrogen proton-
ated (Maresh et al., 2008) (Figure 3), and therefore electrophilic,
while at the same time ensuring that the pyridine moiety of the
aza-indole remains neutral. This highlights the superb capacity
of enzymes to catalyze reactions by selectively protonating
spatially separated functional groups.
The enzymatically active substrates, 4- and 7-aza-tryptamine
1 and 4, were chosen for further analysis in this biosynthetic
pathway, in the steps beyond the Pictet-Spengler reaction
catalyzed by strictosidine synthase (Figure 3). To examine
whether the aza-strictosidine analogs 7 and 10 formed by
strictosidine synthase could be subjected to further enzymaticElsevier Ltd All rights reserved
Figure 3. Reaction of Aza-tryptamines in Monoterpene Indole Alkaloid Biosynthesis
(A) Reaction of aza-tryptamine compounds 1-4 in a Pictet-Spengler reaction.
(B) Formation of downstream alkaloid and aza-alkaloid products.
Figure 4. LC-MS Spectra Showing Production of New Compounds
by Catharanthus roseus When Supplemented with Deglycosylated
Strictosidine Derived from 1 and 4
Starred peaks indicate compounds found only in cultures supplemented with
deglycosylated strictosidine derived from 1 or 4. LC-MS spectra showing the
results of feeding deglycosylated strictosidine 11 derived from natural trypt-
amine 5 to cell cultures are shown in the Supplemental Data.
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Aza-Tryptamine Substrates in Alkaloid Biosynthesistransformations, these compounds were incubated with Cathar-
anthus roseus cell culture that is known to produce a variety of
monoterpene indole alkaloids derived from strictosidine 11
(O’Connor and Maresh, 2006). Coculture of C. roseus with
varying concentrations of 1 and 4, or the corresponding stricto-
sidine synthase products, aza-strictosidines 7 and 10, did not
result in the formation of any new alkaloid compounds as evi-
denced by analysis of the cell culture extracts by liquid chroma-
tography mass spectrometry (LC-MS). However, when 4- and
7-aza-strictosidine 7 and 10 were deglycosylated in vitro by
the strictosidine glucosidase enzyme that acts directly down-
stream from strictosidine synthase, and then cocultured with
C. roseus, we observed a variety of new compounds that were
not present in control cultures lacking aza-indole starting
substrates (Figures 3 and 4). Monoterpene indole alkaloid
biosynthesis is a highly branched pathway in C. roseus, with
over 100 compounds arising from the deglycosylated strictosi-
dine intermediate. The molecular weight of the new compounds
formed appeared to correlate with aza analogs of some these
known alkaloids.
Several compounds with m/z 356 and m/z 354 derived from
4-aza-tryptamine 1 and 7-aza-tryptamine 4 were observed
(Figure 4). Natural tryptamine derived compounds with m/z 353
(corresponding to m/z 354 for the aza-tryptamine analog) in
these cell lines are heteroyohimbine alkaloids, with ajmalicine
12 as themajor compound. Additionally, there are several known
sitsirikine type alkaloids 13 with m/z 355 (corresponding to m/z
356 for the aza-indole analog) that have been previously isolatedChemistry & Biology 16, 1225–122from C. roseus. One of the most abundant unnatural products
(m/z 356, HPLC retention time at 3.6 min), which was derived
from 7-aza-tryptamine 4, was isolated and characterized by
1H-NMR and g-correlated spectroscopy. The 1H-NMR spectrum
of the isolated compound most closely matched that of9, December 24, 2009 ª2009 Elsevier Ltd All rights reserved 1227
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exhibit antineoplastic activity (Mukhopadhyay et al., 1983). NMR
analysis of all isositsirikine stereoisomers have been previously
reported (Lounasmaa et al., 1994). The NMR data for the isolated
aza compound 14 was most consistent with the NMR data re-
ported for (3a, 16R, 19E)-isositsirikine (Lounasmaa et al., 1994)
(Figure 3). (3a, 16R, 19E)-isositsirikine has been previously
isolated from C. roseus cell culture, though typically in small
amounts. Therefore, while the natural isositsirikine alkaloid is
produced in low yields compared with other monoterpene indole
alkaloid classes, the aza-tryptamine substrate 4 preferentially
partitions into this pathway branch.
No compounds with molecular weights consistent with aza-
analogs of catharanthine 15 or tabersonine 16 (m/z 337 for
parent, m/z 338 for aza analog) or akuammicine 17 (m/z 323
for parent,m/z 324 for aza analog), the other major alkaloids nor-
mally observed in C. roseus culture, were observed (Figure 3).
Although heteroyohimbine type alkaloids such as ajmalicine 12
and isositsirikine 13 result from enzymatic reduction of deglyco-
sylated strictosidine (Bernhardt et al., 2009; Hemscheidt and
Zenk, 1985; Stockigt et al., 1983), formation of both catharan-
thine 15, tabersonine 16, and akuammicine 17 require a complex
rearrangement of the deglycosylated strictosidine intermediate
(Qureshi and Scott, 1968; Scott et al., 1971). Although the mech-
anism of this rearrangement remains poorly understood, it
clearly involves the C2 and C3 positions of the indole moiety.
The diminished electron density of the aza-tryptamine sub-
strates 1 and 4 do not appear to be compatible with this rear-
rangement. In contrast, formation of alkaloid products such as
12 and 13 entail a reduction reaction that does not involve partic-
ipation of the indole group, enabling the biosynthesis of milligram
quantities of aza-heteroyohimbine products.
SIGNIFICANCE
By introducing unnatural starting materials to a producing
organism, biosynthetic pathways can be hijacked to yield
novel compounds. Here we have altered tryptamine 5, which
serves as the starting substrate for a variety of alkaloid
biosynthetic pathways, by replacing the indole with one of
four aza-indole isomers. We show that two aza-tryptamine
substrates can be successfully incorporated into the prod-
ucts of the monoterpene indole alkaloid pathway in Cathar-
anthus roseus. A key step of this alkaloid biosynthetic
pathway is an enzymatic Pictet-Spengler reaction that
converts tryptamine 5 and secologanin 6 into strictosidine
11, a tetrahydro-b-carboline product. Two of the electron
deficient aza-tryptamines, 1 and 4, were able to undergo
this enzymatic reaction, resulting in the formation of pyrrolo-
dipyridines 7 and 10, the aza analogs of tetrahydro-b-carbo-
lines. These pyrrolodipyridines could then be transformed
by C. roseus into heteroyohimbine type alkaloids. Use of
unnatural heterocycles in precursor-directed biosynthesis,
in both microbial and plant natural product pathways, has
not been widely demonstrated, and successful incorpora-
tion of starting substrate analogs containing the aza-indole
functionality has not, to the best of our knowledge, been
previously reported. Themost abundant of the aza-alkaloids
produced in C. roseus culture was isolated, characterized1228 Chemistry & Biology 16, 1225–1229, December 24, 2009 ª2009and shown to be an analog of isositsirikine, a natural product
that has demonstrated anti-neoplastic activity. Normally,
the level of isositsirikine inC. roseus culture is low; however,
aza-tryptamine substrate 6 appeared to form this particular
product preferentially compared with other classes of
monoterpene alkaloids. Future efforts will focus on evalua-
tion of the bioactivity of isolated aza-analogs. Additionally,
this work serves as a starting point to explore fermentation
of aza-alkaloids from other tryptophan- and tryptamine-
derived natural product pathways.
EXPERIMENTAL PROCEDURES
Characterization of Compounds 1-4
Compound 1:
1H-NMR (500 MHz, D2O) d 8.40 (d, J = 9.0 Hz, 1H), 8.37 (d, J = 6.0 Hz, 1H),7.93
(s, 1H), 7.56 (d, J = 7.5 Hz, 1H), 7.63 (d, J = 8.0 Hz, 1H), 3.33 (t, J = 7.0 Hz, 2H),
3.19 (d, J = 7.2 Hz, 2H. 13C-NMR (125 MHz, D2O) d 135.2, 134.5, 133.6, 132.7,
128.4, 116.7, 105.0. Exact mass (ESI-TOF): m/z calc (M+H): 162.1026, found:
162.1032.
Compound 2:
1H-NMR (500MHz, D2O) d 8.94 (s, 1H), 8.16 (d, J = 6.5 Hz, 1H), 7.74 (dd, J = 6.5
Hz, 1H), 7.60 (s, 1H), 3.30 (t, J = 7.2 Hz, 2H), 3.16 (t, J = 7.2 Hz, 2H). 13C-NMR
(125 MHz, D2O) d 143.1, 134.4, 131.0, 130.9, 123.9, 113.6, 109.8, 40.0, 22.7.
Exact mass (ESI-TOF): m/z calc (M+H): 162.1026, found: 162.1033.
Compound 3:
1H-NMR (500 MHz, D2O) d 8.79 (s, 1H), 8.05 (d, J = 6.5 Hz, 1H), 7.96 (s, 1H),
7.92 (d, J = 6.5 Hz, 1H), 3.30 (t, J = 7.2 Hz, 2H), 3.14 (d, J = 7.2 Hz, 2H).
13C-NMR (125MHz, D2O) d 137.5, 136.2, 131.1, 127.5, 126.7, 115.3, 112.0,
39.7, 21.9. Exact mass (ESI-TOF): m/z calc (M+H): 162.1026, found: 162.1030.
Compound 4:
1H-NMR (500MHz, D2O) d 8.53 (d, J = 8.0 Hz, 1H), 8.23 (d, J = 5.5 Hz, 1H), 7.49
(s, 1H), 7.44 (t, J = 6,8 Hz, 1H), 3.26 (t, J = 6.8 Hz, 2H), 3.09 (t, J = 7.0 Hz, 2H).
13C-NMR (125MHz, D2O) d 138.8, 137.1, 133.1, 128.2, 125.9, 115.9, 111.9.
Exact mass (ESI-TOF): m/z calc (M+H): 162.1026, found: 162.1024.
Enzyme Assays
Strictosidine synthase (C. roseus) was expressed in E. coli and purified as
previously described (Bernhardt et al., 2009; Maresh et al., 2008; McCoy
et al., 2006). Activity was measured using an high-performance liquid chroma-
tography (HPLC) assay following previously reported procedures (Maresh
et al., 2008). Secologanin (2.5 mM), 1-naphthalene acetic acid as an internal
standard (60 mM), and tryptamine analogs (1–500 mM) in phosphate-buffered
saline (PBS) buffer (50 mM, pH 7.0) were preincubated at 30C. Reactions
were initiated by addition of strictosidine synthase (1–200 nM). The con-
centration of 1 and 4 was calculated from the extinction coefficients (1: 3 =
6006 M1cm1, 4: 3 = 7900 M1cm1, 290 nm, PBS buffer [50 mM, pH 7.0]).
Enzymatic reactions were quenched by addition of 2.0 M aqueous sodium
hydroxide. Quenched aliquots of the reaction were directly injected onto an
analytical HPLC using a solvent gradient of 10% to 70% acetonitrile in 0.1%
aqueous trifluoroacetic acid. The absorbance of tryptamine analogs, strictosi-
dine analogs and NAA were measured at 280 and 290 nm. Peak areas were
integrated and normalized to the internal standard. Initial rates were deter-
mined from the slope by linear least-squares fit of four normalized data points
for each concentration of varied substrate. Kinetic parameters Vmax and Km
were estimated from the initial rates directly fit to appropriate forms of the
Michaelis-Menten equation by nonlinear least-squares fit using Origin 6.0
software (OriginLab Corp.)
Feeding Studies with 1 and 4
To a solution of strictosidine synthase and secologanin (10 mg, 25.8 mmol) in
50 mM PBS buffer (3 ml, pH 7.0) was added 4- or 7-aza-tryptamine 1 or 4
(4.6 mg, 20 mmol) in 50 mM PBS buffer (1 ml, pH 7.0). The reaction mixture
was incubated at 30C for 48 hr. Strictosidine glucosidase was then added
and the mixture was allowed to incubate for an additional 48 hr. The solution
was evaporated, dissolved in 150 ml ethanol and added to C. roseus cellElsevier Ltd All rights reserved
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cultures were allowed to incubate for an additional 7 days, at which point
the cells were filtered and ground inmethanol. Themethanol extract was dried,
redissolved in ethyl acetate, and washed with water. The organic layer was
concentrated, dissolved in methanol and subjected to LC-MS analysis. Ultra-
performance LC analysis was performed on an Acquity Ultra Performance
BEH C18 column with a 1.7 mm particle size, 2.1 3 100 mm dimension, and
a flow rate of 0.6 ml min1 in tandem with a Micromass LCT Premier TOF
Mass Spectrometer with an ESI source (Waters Corporation). The capillary
and sample cone voltages were 3000 V and 30 V, respectively. The desolvation
and source temperatures were 300 and 100C, respectively. The cone and
desolvation gas flow rates were 60 and 800 l hr1. Analysis was performed
with MassLynx 4.1. Compound 14 was purified from reverse phase prepara-
tive HPLC using a gradient of 0%–30%acetonitrile in water with 0.1% trifluoro-
acetic acid over 40 min.
7-Aza-isositsirikine (3a, 16R, 19E) 14
1H-NMR (600 MHz, CD3OD) d 8.25 (d, J = 3.7 Hz, 1H), 8.00 (d, J = 7.7 Hz, 1H),
7.17 (dd, J = 7.7 Hz, 4.9 Hz, 1H), 6.04 (q, J = 6.7 Hz, 1H), 3.88 (m, 3H), 3.78
(s, 3H), 3.70 (m, 3H), 3.56 (m, 2H), 3.19 (m, 1H), 3.06 (m, 1H), 2.62 (m, 2H),
2.46 (m, 2H). Exact mass (ESI-TOF): m/z calc (M+H): 356.1969, found:
356.1974.
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